HLB Co., Ltd. (KOSDAQ:028300)
South Korea · Delayed Price · Currency is KRW 37,750
+100 (0.26%)
Aug 29, 2025, 3:30 PM KST
HLB Co., Ltd. Market Cap
HLB Co., Ltd. has a market cap or net worth of 4.95 trillion as of August 29, 2025. Its market cap has decreased by -51.19% in one year.
Market Cap
4.95T
Enterprise Value
5.10T
Revenue
75.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
37,750.00
Market Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 4.95T, an increase of 36,693.09%. That is a compound annual growth rate of 42.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 4,952.16B | -48.34% |
| Dec 30, 2024 | 9,585.71B | 46.53% |
| Dec 28, 2023 | 6,541.97B | 98.02% |
| Dec 29, 2022 | 3,303.67B | -10.84% |
| Dec 30, 2021 | 3,705.38B | -24.18% |
| Dec 30, 2020 | 4,887.34B | -0.25% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.60T |
| Celltrion | 37.63T |
| ALTEOGEN | 22.61T |
| Yuhan | 8,694.51B |
| SK Biopharmaceuticals | 7,878.31B |
| PharmaResearch | 7,314.31B |
| Peptron | 7,303.72B |
| LigaChem Biosciences | 5,379.81B |